{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:58:29Z","timestamp":1768323509308,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T16:57:35Z","timestamp":1464713855000},"page":"2047-2054","source":"Crossref","is-referenced-by-count":26,"title":["Association of Hyperhomocysteinemia with Stroke Recurrence after Initial Stroke"],"prefix":"10.1016","volume":"25","author":[{"given":"Emre","family":"Kumral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcls\u00fcm","family":"Saruhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilara","family":"Aktert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Orman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0015","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/STROKEAHA.107.513416","article-title":"Homocysteine and its relationship to stroke subtypes in a UK black population: the South London Ethnicity and Stroke Study","volume":"39","author":"Khan","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0020","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/STROKEAHA.115.009111","article-title":"Homocysteine, ischemic stroke, and coronary heart disease in hypertensive patients: a Population-Based, Prospective Cohort Study","volume":"46","author":"Han","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/STROKEAHA.113.004099","article-title":"Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke","volume":"45","author":"Kwon","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0030","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/STROKEAHA.115.009136","article-title":"Elevated total homocysteine levels in acute ischemic stroke are associated with long-term mortality","volume":"46","author":"Shi","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0035","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1179\/1743132813Y.0000000228","article-title":"Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke","volume":"35","author":"Tu","year":"2013","journal-title":"Neurol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejim.2013.01.015","article-title":"Acute phase homocysteine related to severity and outcome of atherothrombotic stroke","volume":"24","author":"Wu","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2008.11.011","article-title":"Are plasma homocysteine levels related to neurological severity and functional outcome after ischemic stroke in the Korean population?","volume":"278","author":"Song","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.apmr.2004.01.031","article-title":"Plasma homocysteine level and functional outcome of patients with ischemic stroke","volume":"86","author":"Mizrahi","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/hs0202.103069","article-title":"Changes in plasma homocyst(e)ine in the acute phase after stroke","volume":"33","author":"Howard","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0060","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10072-004-0219-5","article-title":"Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke","volume":"25","author":"Parnetti","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000015866","article-title":"The Ege Stroke Registry: a hospital-based study in the Aegean Region, Izmir, Turkey","volume":"8","author":"Kumral","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Stroke\u20141989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders","volume":"20","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gheart.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"7","author":"Thygesen","year":"2012","journal-title":"Glob Heart"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0090","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1161\/STROKEAHA.109.561365","article-title":"Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale","volume":"40","author":"Hong","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2007.09.029","article-title":"Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study","volume":"198","author":"Cui","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/CS20090142","article-title":"High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population","volume":"118","author":"Zhang","year":"2010","journal-title":"Clin Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0105","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.031","article-title":"C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients","volume":"22","author":"Naess","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0110","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/01.CIR.0000131942.77635.2D","article-title":"Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese","volume":"109","author":"Iso","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2006.06.028","article-title":"The relationship between homocysteine, cognition and stroke subtypes in acute stroke","volume":"250","author":"Tay","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0120","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/STROKEAHA.114.005208","article-title":"Effect of genetic variants associated with plasma homocysteine levels on stroke risk","volume":"45","author":"Cotlarciuc","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0125","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.STR.0000069017.78624.37","article-title":"Homocysteine and risk of recurrent stroke","volume":"34","author":"Boysen","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000047687","article-title":"Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients","volume":"12","author":"Del Ser","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-135-2-200107170-00014","article-title":"Power Shortage: clinical trials testing the \u201chomocysteine hypothesis\u201d against a background of folic acid-fortified cereal grain flour","volume":"135","author":"Bostom","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.0000106481.59944.2F","article-title":"Inflammation, homocysteine, and vitamin B6 status after ischemic stroke","volume":"35","author":"Kelly","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0145","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2377-8-26","article-title":"Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians","volume":"8","author":"Okubadejo","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.STR.32.1.57","article-title":"Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke","volume":"32","author":"Meiklejohn","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCOUTCOMES.109.910711","article-title":"Future cardiovascular disease in China: Markov model and risk factor scenario projections from the coronary heart disease policy model-China","volume":"3","author":"Moran","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1515\/cclm-2012-0465","article-title":"B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes","volume":"51","author":"Spence","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.05.008_bib0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716300635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716300635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T14:58:42Z","timestamp":1536677922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305716300635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1052305716300635"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.05.008","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}